Pedaling Exercises for Disability and Activity Limitations
NCT ID: NCT01391949
Last Updated: 2022-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
7 participants
INTERVENTIONAL
2011-07-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Self-Motivating Messages to Encourage People to Exercise More
NCT02903849
CalFitness Smartphone-Delivered Physical Activity Intervention With Messaging
NCT03148145
Effect of Comprehensive Rehabilitation at Beitostølen Healthsports Centre
NCT01788397
Intervention to Reduce Sedentary Time
NCT02878486
Physical Activity Counseling During Pulmonary Rehabilitation
NCT00948623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Detailed feedback
Subjects will pedal on the UCFit with a goal of 30 total minutes of daily exercise.
Detailed feedback
Once a week subjects will receive feedback about the total time spent cycling and walking in the previous week. Subjects in this intervention group will also receive feedback about average cycling speed, distance pedaled, average walking speed, and distance walked in the previous week.
Basic feedback
Subjects will pedal on the UCFit with a goal of 30 total minutes of daily exercise.
Basic feedback
Once a week subjects will receive feedback about total time spent cycling and walking in the previous week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Detailed feedback
Once a week subjects will receive feedback about the total time spent cycling and walking in the previous week. Subjects in this intervention group will also receive feedback about average cycling speed, distance pedaled, average walking speed, and distance walked in the previous week.
Basic feedback
Once a week subjects will receive feedback about total time spent cycling and walking in the previous week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no major contraindications to participating in light-to-moderate exertion
* able to follow and retain verbal directions to carry out simple lower extremity repetitive exercises
* planned discharge to home with family available to assist
Exclusion Criteria
* body mass index \>30
* fractures or contractures that prevent use of an extremity for pedaling
* impairment in cognition that precludes a full understanding of the risks and benefits of this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruce H. Dobkin
Professor of Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Dorsch, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Bruce Dobkin, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Los Angeles
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-001404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.